Akebia Therapeutics (AKBA)

Akebia Therapeutics (AKBA) Financial Statements


Akebia Therapeutics Financial Overview

Akebia Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.533; its P/E ratio is -2.21; Akebia Therapeutics is scheduled to report earnings on November 9, 2023, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 42.24M$ 40.13M$ 55.18M$ 48.96M$ 126.76M
Gross Profit$ 48.10M$ 40.13M$ 55.18M$ 11.02M$ 108.16M
EBIT$ -9.27M$ -15.74M$ -15.51M$ -47.91M$ 34.31M
EBITDA$ 123.00K$ -6.35M$ 42.26M$ -38.49M$ 43.74M
Net Income Common Stockholders$ -11.17M$ -26.22M$ -7.55M$ -51.87M$ 29.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 53.57M$ 57.00M$ 90.47M$ 144.76M$ 143.89M
Total Assets$ 253.67M$ 276.86M$ 351.83M$ 435.89M$ 521.80M
Total Debt$ 53.97M$ 77.71M$ 95.04M$ 100.89M$ 134.31M
Net Debt$ 394.00K$ 20.71M$ 4.57M$ -43.87M$ -9.58M
Total Liabilities$ 280.52M$ 291.21M$ 342.49M$ 422.04M$ 459.50M
Stockholders Equity$ -26.81M$ -14.35M$ 9.34M$ 13.85M$ 62.30M
Cash Flow-
Free Cash Flow$ 3.64M$ -17.58M$ -54.68M$ 33.80M$ -30.66M
Operating Cash Flow$ 3.64M$ -17.58M$ -54.68M$ 33.80M$ -30.66M
Investing Cash Flow---$ 0.00$ 0.00
Financing Cash Flow$ -8.00M$ -15.97M$ -1.00K$ -32.94M$ -9.00K
Currency in USD

Akebia Therapeutics Earnings and Revenue History

Akebia Therapeutics Debt to Assets

Akebia Therapeutics Cash Flow

Akebia Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis